At Genique Lifesciences, we believe that understanding a patient's genome is the key to transforming diabetes management from reactive to proactive.
The genetic blueprint behind diabetes
While type 1 diabetes is largely autoimmune, type 2 diabetes, the most common form, arises from a complex interaction between genes and lifestyle factors. Scientists have identified over 400 genetic variants linked to diabetes, influencing insulin production, glucose regulation, and fat metabolism.
For instance, variations in genes such as TCF7L2, PPARG, and KCNJ11 can affect how efficiently the body uses insulin or processes glucose. This genetic variability explains why two people with similar routines can experience completely different health outcomes, because their DNA defines their baseline risk.
Genomic screening: detecting risk before it manifests
Traditional diabetes screening methods such as blood glucose and HbA1c tests, detect the condition only after physiological changes occur. Genomic screening, however, identifies predispositions much earlier.
By evaluating multiple gene variants through a Polygenic Risk Score (PRS), genomic testing estimates an individual's inherited likelihood of developing diabetes. When combined with environmental and lifestyle data, it creates a comprehensive risk profile.
Used this way, a genetic risk estimate helps clinicians and patients plan targeted lifestyle adjustments long before diabetes develops, turning awareness into prevention.
Personalised management through genomic insight
Genomics also reshapes how diabetes is managed after diagnosis. Certain gene variants affect how patients metabolise medications like metformin, influencing efficacy and side effects. Research is exploring whether genetics can guide nutrition strategies, such as whether an individual benefits more from a low-carb, Mediterranean or high-fibre diet, though trials such as DIETFITS have not yet found that genotype predicts which diet works best. Even exercise response and glucose utilisation patterns are genetically influenced.
By combining these insights, personalised diabetes care becomes a reality, so that each plan takes an individual's genetic profile into account.
Empowerment through early insight
For individuals with a family history of diabetes, genomic screening ordered through their clinician offers clarity, direction, and empowerment. It helps identify inherited risks before symptoms appear, enables early preventive action through tailored recommendations, and supports precision treatment based on genetic response.
For healthcare professionals, integrating genomic data enhances preventive care, allowing for proactive and precise patient support.
The genomic era of diabetes care
The future of diabetes care lies in personalisation, and genomics is leading that transformation. By decoding how genes influence disease susceptibility, drug response, and metabolic efficiency, we can shift diabetes care from management to prevention.
At Genique Lifesciences, we're bridging the gap between genetics and everyday wellness, by giving the clinics, laboratories and partners who order our screening reports what they need to help individuals understand their risks, personalise their care and take control of their health.
Because when it comes to diabetes, your genome doesn't just hold the risk; it holds the roadmap to prevention.